Biobanking Devices Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Biobanking devices represent the physical infrastructure required to collect, process, and store biological specimens at ultra-low temperatures or controlled conditions. The $7.65 billion valuation for 2025 reflects the equipment segment specifically, while a closely related biobank consumables market is separately valued at roughly $2.01 billion. These figures are compiled by private market research firms rather than official government statistical agencies.

• •Market valued at $7.65 billion in 2025 for the devices and equipment segment
• •Projected to reach $11.82 billion by 2030 at 9.1% CAGR
• •Companion consumables market estimated separately at $2.01 billion with 8.40% CAGR

The expansion of personalized medicine and targeted therapies has increased demand for high-quality biological sample repositories. Additionally, advances in genomic research and the growing prevalence of chronic diseases have spurred investments in large-scale biobanking infrastructure. Government and private funding for biomedical research across North America, Europe, and Asia-Pacific further fuels equipment procurement.

• •Rising investment in genomic research and personalized medicine initiatives
• •Increased prevalence of chronic and infectious diseases driving sample collection
• •Growing government and private funding for biomedical research infrastructure

The market is generally segmented by product type, including ultra-low temperature freezers, $-80°C freezers, liquid nitrogen tanks, and refrigerators. Geographically, North America holds a significant share due to extensive research funding and established healthcare infrastructure, while the Asia-Pacific region is expected to see the fastest growth. Equipment segments account for roughly 41.8% of the broader biobanking market in some analyses.

• •North America leads due to strong research funding and healthcare infrastructure
• •Asia-Pacific projected as the fastest-growing region
• •Equipment segment represents approximately 41.8% of the broader biobanking market

What are the recent trends and outlook?

Automation and digital sample tracking are becoming increasingly important as biobanks scale up operations and seek to minimize human error. Cloud-based laboratory information management systems are being integrated with physical storage equipment to enable real-time inventory monitoring. The market is expected to maintain steady growth through 2030, supported by ongoing pharmaceutical research and the continued expansion of population-scale biobanking projects.

• •Growing integration of automation and digital tracking in biobank operations
• •Cloud-based inventory management systems increasingly paired with storage equipment
• •Market projected to sustain ~9% annual growth through 2030